), are expensive and variable in their efficacy. They also require protracted courses of parenteral administration and have toxic side effects, 1) which often result in the interruption of treatment. Furthermore, the increasing resistance to antimonial drugs in many parts of the world clearly indicates the need for a more effective and safer chemotherapeutic approach.
Based on ethnomedical information obtained from populations which use traditional remedies, new antileishmanial products like quinoline alkaloids have been discovered during the last decade.
2) Improving efficacy of chemotherapeutic treatment by introducing structural modifications within these new drugs constitutes a major goal.
Because the introduction of fluorine into molecules modifies the physiological activity of the resulting compounds, the development of fluorinated analogues has received increasing attention in recent years. We wish to present the methodology we used in the preparation of 2-propyltrifluoromethylquinolines 1 and the chemical transformations of trifluoromethylquinaldines 2 into 2-alkenyl and 2-epoxypropyltrifluoromethylquinolines via the corresponding aldehydes. Preliminary in vitro evaluation of these synthetic compounds will be presented.
Chemistry In a previous paper, 3 ) Song has described the synthesis of 6-and 7-fluorinated quinaldines by the Skraup reaction from the corresponding fluorinated anilines. We have revisited this reaction with poorly nucleophilic trifluoroanilines which were converted into 2-propyltrifluoromethylquinolines 1a-d. The best yields were obtained by changing p-chloranil with air flow as the oxidant in refluxing butanol. The use of m-trifluoromethylaniline gave access to 1b and 1d in a 10/1 ratio (Chart 1).
In order to introduce a trifluoromethyl group on the pyridine ring of the quinoline skeleton, we have first studied the cyclization of the trifluoromethylenaminone 4 (Chart 1). Condensation of 1-pentynyllithium with 1,1-difluoroethyltrifluoroacetate in the presence of BF 3 -Et 2 O gave access to 3 which was transformed into 4 after a Michael reaction with aniline. Initial attempts at cyclization of 4 using a variety of Lewis acids (AlCl 3 , BF 3 -Et 2 O or TiCl 4 ) failed, resulting in only the recovery of starting material. The use of trifluoroacetic or sulfuric acid leads to traces of quinoline 1e in a mixture of tarry matters. The yield was finally substantially improved in polyphosphoric acid (24 h, reflux, 63%).
To prepare the 2-propyl-3-trifluoromethylquinoline 1f, we first synthesized the 2-propyl-3-iodoquinoline 5 by the use of a large excess of propyllithium on 3-aminoquinoline, followed by diazotisation and subsequent treatment with potassium iodide. Considerable attention has been devoted to finding methods for introducing the trifluoromethyl group onto aromatic halide compounds. For example, Kobayashi 4) prepared a trifluoromethylcopper species by the reaction of CF 3 I with activated copper in DMF, Matsui 5) has developed a convenient trifluoromethylation of aromatic halides with sodium trifluoroacetate, and Fuchikami 6) used the (CF 3 SiMe 3 /KF/ CuI) system for trifluoromethylation of halides. Best results were obtained in the preparation of 1f by using difluorocarbenes generated from methylchlorodifluoroacetate in the presence of KF and CuI in DMF 7) (Chart 1). To prepare 2-propenyltrifluoromethylquinolines 7 and 2-epoxypropyl-trifluoromethylquinolines 8, we first synthesised the quinaldines 2 as described for 1. The transformation of quinaldines into 2-quinolinecarboxaldehydes 6 with SeO 2 in dioxane was not affected by the electron-withdrawing effect of the trifluoromethyl group.
Synthesis of 2-Substituted
Wittig olefination with ethyltriphenylphosphonium iodide afforded 2-propenyltrifluoromethylquinolines 7 as single E isomers in good yields. To prepare 2-epoxypropylpropyleneoxyde-trifluoromethylquinolines 8 as fluorinated analogues of the natural product isolated by Fournet, 2) we used the reaction of the sulfur ylide generated from ethyldiphenylsulfoniumtetrafluoroborate on 2-trifluoromethylquinolinecarboxaldehydes 6 as previously described by Brochet 8) and us. 9) Epoxides were then obtained in good yields as a separable mixture of Z and E isomers (1/1). The stereochemistry of these epoxides was determinated by studying their 1 H-NMR spectra : measure of J H 2 Ј-H 3 Ј (4.5 and 2 Hz for Z and E isomers respectively), NOE experiments and comparison with the 1 H-NMR spectra of the E antileishmanial natural epoxide. 9) We have also synthesized the 2-(3,3,3-trifluoropropyl) quinoline 9 by the use of a Grignard reagent on N-quinolineoxide, but a more efficient way consisted in the preparation of the lithium salt of 3-bromo-1,1,1-trifluoromethylpropane that reacts with quinoline to give 9 in a 60 % yield (Chart 3).
Antileishmanial Activity Various in vitro tests were used to assess the antileishmanial activity of 2-substituted trifluoromethylquinolines. These tests have been done at both the Pasteur Institute (Paris, France) and at the Swiss Tropical Institute (Basel, Switzerland). They were based upon the use of axenic amastigotes and peritoneal or bone marrow-derived mouse macrophages infected with amastigotes from different Leishmania species, including L. donovani (MHOM/ET/ 1967/L82), L. infantum (IPZ 229/1/89) and L. amazonensis (MPRO/BR/1972/M1841).
The reference drugs used were sodium stibogluconate, amphotericin B, allopurinol or allopurinol riboside and leucinemethyl ester (L. amazonensis). For all the tests, these products showed consistent and reproductible leishmanicidal activity proving the validity of our assays.
Unfortunately, the various molecular changes made on natural products did not further improve their activity. On the contrary, for all the compounds we have tested, i.e., 2-alkyl, 2-alkenyl and 2-epoxypropyl-trifluoromethylquinolines, we have noted a decrease of antileishmanial activity compared to control drugs and natural products. For example, from a concentration of 1.5 mg/ml, the natural 2-prop-1-enylquinoline showed a leishmanicidal activity against Leishmania amazonensis; in contrast, trifluoromethylated analogues were only efficient at a concentration of 50 mg/ml. The 2-propylquinoline was active at 12.5 mg/ml, whereas 1f (the most efficient compound 1) was only active at 25 mg/ml. The 2-epoxypropyltrifluoromethylquinolines were poorly active around 100 mg/ml.
Preliminary works point out that natural quinolines, such as 2-propylquinoline, are transformed in liver cells into oxidized metabolits. 10) Moreover, these metabolits should be the active drugs because the natural 2-propylquinoline is more efficient by oral administration than by parenteral route.
11)
The introduction of a trifluoromethyl substituent must prevent or slow down this oxidizing mechanism which could explain the above antileishmanial results. Introduction of electro-donnor groups on 2-substituted-quinolines should give highly promising results. C, respectively). Analytical thin-layer chromatography was performed on Merck silica gel 60F 254 glass precoated plates. All liquid chromatography separations were performed using Merck silica gel 60 (230-400 mesh ASTM). Elemental analyses 12) were performed by the Service de microanalyses, Centre d'Etudes Pharmaceutiques, Châtenay-Malabry, France, with a Perkin Elmer 2400 analyzer.
2-Propyltrifluoromethylquinolines 1a-d
A mixture of trifluoromethylaniline (30 mmol), butanol (40 ml), HCl 12 N (10 ml) was heated under reflux and then trans-hexenal (150 mmol) was slowly added. The resulting solution was heated under reflux and under draught for 8 h. The cooled reaction mixture was made alkaline with KOH and extracted with CH 2 Cl 2 . After drying, and the removal of the solvent, chromatographic purification on silica gel afforded the desired quinolines.
2-Propyl-8-trifluoromethylquinoline 1a: 52%. 2-Methyl-trifluoromethylquinolines 2a,b These compounds were prepared as described above by changing trans-butenal to trans-hexenal. 1,1,1-Trifluoromethylhept-3-yn-2-one 3 Butyllithium (1.6 M in hexane, 46 ml, 74 mmol) was added to pent-1-yne (4.59 g, 67 mmol) in THF (120 ml) at Ϫ78°C and this mixture was stirred at this temperature for 30 min. 2,2-difluoroethyl trifluoroacetate (13.35 g, 75 mmol) in THF (100 ml) was added followed immediately by boron trifluoride-diethyl ether complex (11.3 g, 80 mmol). The mixture was stirred at Ϫ78°C for 90 min. Saturated aqueous ammonium chloride (40 ml) was added and the solution was allowed to warm to ambient temperature. The THF was evaporated and the residue, taken up in dichloromethane, was washed with water and twice with brine and dried. The residue was then purified by silica gel column chromatography to give 3 (9.1 g , 85% 2-Propyl-4-trifluoromethylquinoline 1e 4 (2 g, 7.8 mmol) and polyphosphoric acid (10 ml) were stirred under reflux for 24 h. The cooled reaction mixture was basified with KOH (1 N, 40 ml) and extracted with dichloromethane. After drying, and the removal of the solvent, chromatographic purification on silica gel afforded 1e (1.17 g, 63% 3-Iodo-2-propylquinoline 5 tert-Butyllithium (1.5 M in pentane, 35.5 ml) was slowly added at Ϫ78°C to a stirred solution of iodopropane (5.1 g, 30 mmol) in ether. The mixture was stirred 30 min at this temperature and allowed to warm to 0°C for 1 h. The solution was then cooled at Ϫ78°C and 3-aminoquinoline (1.44 g, 10 mmol) in ether (10 ml) was slowly added. After stirring 24 h at ambient temperature, the solution was quenched by the addition of saturated aqueous NH 4 Cl. After extraction (CHCl 3 ), the solution was dried and concentrated. The crude product was subjected to chromatography to give 3-amino-2-propylquinoline (1.16 g, 60%). This latest compound (1.12 g) was dissolved in acetic acid (18 ml) at 0°C and sodium nitrite (1.48 g, 21.5 mmol) in H 2 O (10 ml) then potassium iodide (3.57 g, 21.5 mmol) in H 2 O (15 ml) were added to the mixture. After 2 h, the solution was treated with NaOH (1 N, 30 ml) and extracted with dichloromethane, then dried. After evaporation, the residue was purified by silica gel column chromatography to give 5 (1.02 g, 57%). 
